The role of peroxisome proliferator-activated receptor-b/ d (PPAR-b/d) in the pathogenesis of colon cancer remains highly controversial. This study specifically silenced the PPAR-b expression in three colon cancer cell lines with different metastatic potentials. Although PPAR-b knockdown resulted in more malignant morphological changes, bigger colony sizes and lower carcinoembryonic antigen (CEA) secretion, and enhanced the cell-fibronectin adhesion, cell invasion and migration were unaffected. These effects were stronger in poorly metastatic cell lines compared with highly metastatic ones. Simultaneously, PPAR-b knockdown decreased the mRNAs encoding adipocyte differentiation-related protein and liver fatty acid binding protein, and increased the mRNA of ILK, whereas the mRNAs encoding integrin-b1 and angiopoietin-like 4 were unchanged. Using immunohistochemistry, we determined that the intensity of PPAR-b expression was stronger in rectal cancers with better differentiation than in those with poor differentiation, and was stronger in early-stage tumors than in advanced ones. Together, these findings consistently indicate that PPAR-b may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a role as an inhibitor in the carcinogenesis and progression of colorectal cancer. Interestingly, PPAR-b seems to have a more important role in poorly metastatic cells than in highly metastatic ones.
Introduction
Peroxisome proliferator-activated receptor-b/d (PPARb/d) is a ligand-activated transcription factor of the nuclear hormone receptor superfamily (Kliewer et al., 1994) . Recent studies suggest that PPAR-b may be involved in the pathogenesis of colon cancer. Inactivation of adenomatous polyposis coli upregulates PPAR-b expression in colon cancer (He et al., 1999) , and genetic disruption of PPAR-b in colon cancer cells shows a decreased growth of xenografts (Gupta et al., 2000) . Nonsteroidal anti-inflammatory drugs induce the apoptosis of colon cancer cells through direct inhibition of PPAR-b DNA-binding activity (Kliewer et al., 1994; Ouyang et al., 2006) . Activation of K-ras oncogene promotes the PPAR-b expression in rat intestinal epithelia (Shao et al., 2002) . These studies support a promotive role of PPAR-b in colon carcinogenesis. However, other studies conflict with those reports. Targeted deletion of adenomatous polyposis coli alleles reduces PPAR-b expression in mouse intestine (Reed et al., 2004) . PPAR-b expressions in human colorectal cancers or intestinal polyps of adenomatous polyposis coli (min) mice are either unchanged or downregulated as compared with normal controls (Orner et al., 2003; Chen et al., 2004; Yang et al., 2006) . Experiments that examined polyp formation in PPAR-b-null adenomatous polyposis coli (min) mice show either no effect (Barak et al., 2002) or, paradoxically, an increase in polyp number and size compared with wild-type mice . Therefore, the exact role of PPAR-b in the pathogenesis of colon cancer is not yet fully elucidated.
Our previous study has shown that PPAR-b may inhibit the proliferation of HCT-116 colon cancer cells (Yang et al., 2008) . Recent literatures suggest that PPAR-b activation induces the terminal differentiation of keratinocytes, coupled with the inhibition of cell proliferation (Schmuth et al., 2004; Kim et al., 2006; Burdick et al., 2006) . These studies enable us to hypothesize that PPAR-b possibly has some role in the differentiation of colon cancer, and might affect the cell adhesion, migration and/or invasion that are associated with tumor differentiation. To examine this hypothesis, we used the lentivirus-mediated RNA interference to specifically suppress the PPAR-b expression in colon cancer cell lines, and then analysed the alterations of these cells in morphology, colony formation ability, carcinoembryonic antigen (CEA) secretion, as well as in the abilities of adhesion, invasion and migration.
Results

Lentivirus-short hairpin PPAR-b (Lenti-shPPAR-b)-mediated efficient PPAR-b knockdown
We used lentivirus-mediated RNA interference to silence the expression of PPAR-b in colon cancer cell lines. At 48 h after infection, we observed a highly efficient transduction (>90%) of Lenti-shPPAR-b in KM12C, KM12SM and KM12L4a cells by analysing enhanced green fluorescent protein expression under a fluorescent microscope ( Figure 1a ). Using flow cytometry, we confirmed that transduction efficiency was 93.4% in KM12C, 91.9% in KM12SM and 94.0% in KM12L4a cells (Figure 1a ). Lenti-control showed similar transduction efficiencies as Lenti-shPPAR-b (data not shown). Using quantitative reverse transcriptase-PCR, we showed that Lenti-shPPAR-b reduced PPAR-b mRNA expression by approximately 70.0, 75.2 and 75.5% in KM12C, KM12SM and KM12L4a cells, respectively, relative to that of untreated cells (Po0.05), whereas Lenti-control had no significant effect on the PPAR-b mRNA level (P>0.05, using the software REST-XL (available at http://www.wzw.tum.de/genequantification/); Figure 1b) . Western blot revealed an obvious reduction in PPAR-b protein expression in the Lenti-shPPAR-b-treated groups of the three cell lines and showed no obvious difference between the Lenticontrol-treated group and untreated group (Figure 1c) .
Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown induced obvious morphological changes indicative of less differentiation Using hematoxylin and eosin (Sigma-Aldrich, Stockholm, Sweden) staining, scanning electronic microscopy and transmission electronic microscopy, we found that the Lenti-shPPAR-b-treated KM12C, KM12SM and KM12L4a cells had concordant morphological changes indicative of less differentiation. By hematoxylin and eosin staining, the untreated cells showed a fairly uniform small round shape and moderately stained nuclei, whereas Lenti-shPPAR-b-treated cells assumed varying sizes and obvious pleomorphism, with more irregular and strongly stained nuclei (Figure 2a ). These changes seemed to be greater in KM12C cells than in KM12SM and KM12L4a cells. Scanning electronic microscopy images showed that Lenti-shPPAR-b-treated cells had a greater density of microvilli on their surfaces than The role of PPAR-b in colon cancer L Yang et al did untreated cells (Figure 2b ). Using transmission electronic microscopy, Lenti-shPPAR-b-treated cells showed much fewer organelles, especially mitochondria in the cytoplasm than did untreated cells (Figure 2c ). The Lenti-control did not show any effect on cell morphology.
Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown increased colony size We next seeded limited numbers of KM12C, KM12SM and KM12L4a cells as single-cell suspensions in six-well plates to examine the effect of PPAR-b knockdown on the clonogenicity of colon cancer cells. After 5 days of incubation, we observed colonies in all the groups and noticed that most colonies in LentishPPAR-b-treated groups were significantly larger compared with those in Lenti-control-treated or untreated groups (Figure 3) . However, there was no significant difference in the colony formation efficiencies of KM12C, KM12SM or KM12L4a cells among the groups, although the Lenti-shPPAR-b group showed a slightly higher colony formation efficiencies than did the other groups (P>0.05, analysis of variance (ANOVA); Table 1 ).
Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown decreased carcinoembryonic antigen (CEA) secretion of cells The influence of PPAR-b knockdown on the CEA secretion of KM12C, KM12SM and KM12L4a cells was examined using enzyme-linked immunosorbent assay. Whereas the CEA production of KM12C, KM12SM and KM12L4a cells treated with Lenti-shPPAR-b was reduced by 3.0-, 2.1-and 1.7-fold, respectively, relative to that of untreated cells ( Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown enhanced cell adhesion to fibronectin We examined the effect of PPAR-b knockdown on the attachment of KM12C, KM12SM and KM12L4a cells to fibronectin using extracelluar adhesion assay. In this assay, nonadherent cells were removed and the remaining adherent cells were fixed and stained, and observed under a light microscope. As shown in Figure 4a , KM12C, KM12SM and KM12L4a cells treated by Lenti-shPPAR-b became much more adherent compared with Lenti-control and untreated cells. The adherent cells were then solubilized and measured at 550 nm. As shown in Figure 4b , the absorbance of Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown had no effect on cell migration and invasion The effects of PPAR-b knockdown on cell migration and invasion were examined according to the Boyden chamber principle. Neither migration nor invasion of KM12C, KM12SM and KM12L4a cells was affected by Lenti-PPAR-b treatment compared with Lenticontrol and untreated groups (P>0.05, ANOVA; data not shown).
Peroxisome proliferator-activated receptor-b (PPAR-b) knockdown modulated target gene expression associated with terminal differentiation and cell attachment After the knockdown of PPAR-b, the mRNAs encoding adipocyte differentiation-related protein (ADRP) and liver fatty acid binding protein (L-FABP) were decreased, and the mRNA encoding integrin-linked kinase (ILK) was increased in all the three colon cancer cell lines (Po0.05, REST-XL; Figure 5 ). No such changes were observed in Lenti-control-treated cells (P>0.05, REST-XL). The knockdown of PPAR-b did not alter the mRNAs encoding angiopoietin-like 4 (ANGPTL4) and integrin-b1 (P>0.05, REST-XL; data not shown).
Intensity of peroxisome proliferator-activated receptor-b (PPAR-b) expression was associated with the differentiation and tumor-node-metastasis stage of rectal cancer Stained using immunohistochemistry, rectal cancers with better differentiation showed a significantly higher strong-intensity rate of PPAR-b expression than did those with poor differentiation (P ¼ 0.004, chi-square test; Table 3 ). The strong intensity of PPAR-b expression was much more frequent in tumors in early stage (stages I and II) than in advanced ones (stages III and IV; P ¼ 0.015, chi-square test; Table 3 and Figure 6 ). The role of PPAR-b in colon cancer L Yang et al The role of PPAR-b in colon cancer L Yang et al
Discussion
The role of PPAR-b in colon carcinogenesis remains controversial because of disparities in literature. In this study, we found that the knockdown of PPAR-b resulted in obvious changes indicative of less differentiation in KM12C, KM12SM and KM12L4a cell lines, leading to more malignant morphological changes, increased colony sizes and decreased CEA production, and enhanced cell-fibronectin adhesion of these cells.
These findings indicate that PPAR-b may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer cells, likely having a protective role in the carcinogenesis and progression of colon cancer. It has been shown that less-differentiated colon cancers, compared with more-differentiated ones, assume a more malignant morphology, as represented by obvious polymorphism with more irregular nuclei, and show higher abilities of proliferation and colony formation, coupled with less CEA secretion (Bordonaro et al., 2002; Hinnebusch et al., 2002; Park et al., 2005) . Thus, the finding that PPAR-b knockdown caused more malignant morphology, larger colonies and less CEA production in KM12C, KM12SM and KM12L4a cells shows that PPAR-b knockdown induces less differentiation of both poorly and highly metastatic colon cancer cells, indicating that PPAR-b facilitates the differentiation of colon cancer. In line with this finding, the immunohistochemistry analysis in this study showed that the rectal cancers with better differentiation had a much stronger intensity of PPAR-b expression than those with poor differentiation. This is consistent with the recent report that induced differentiation of HT-29 cells is accompanied by an increase in PPAR-b expression (Aung et al., 2006) .
Peroxisome proliferator-activated receptor-b is a transcription factor with a number of well-defined target genes that could affect cancer biology; of these targets, ADRP and L-FABP are shown to be associated with colon differentiation (Schroeder et al., 2001 ; Targett Our finding that PPAR-b knockdown enhanced the cell-fibronectin adhesion of KM12C, KM12SM and KM12L4a cells without influence on cell invasion and migration suggests that PPAR-b may inhibit the cell-fibronectin adhesion of colon cancer cells, while having no effect on migration and invasion. As a higher ability of cell adhesion to extracelluar matrix represents a higher malignancy of cancer (Alexandrova, 2008) , this finding implies a protective role of PPAR-b in colon cancer progression, which is consistent with its effect on the cell differentiation observed in this study. Using immunohistochemistry, we found that the PPAR-b expression was stronger in early-stage tumors than in advanced-stage ones, showing that the decrease in PPAR-b expression is associated with the progression of rectal cancer, which also indicates its protective role in rectal cancer progression. Besides, cell-extracelluar matrix adhesion not only serves as a mechanical support for cells but also initiates discrete intracellular signaling that regulates various cell activities, including proliferation, morphogenesis and differentiation (Worth and Parsons, 2008; Wozniak, 2004; Reddig and Juliano, 2005) . Therefore, the increased cellfibronectin adhesion by PPAR-b knockdown likely underlies the less differentiation changes of the colon cancer cells in this study.
The interaction of cells with fibronectin regulates intracellular and extracellular functions through integrin-mediated signal transduction, which requires interaction of integrin cytoplasmic domains with cellular proteins. ILK is the binding partner of integrin, associating with the cytoplasmic domain of integrin b1 and mediating integrin-dependent cell attachment (Hannigan et al., 1996) . Inhibition of ILK activity or expression results in the inhibition of cell adhesion by its downstream signaling to protein kinase B/Akt and glycogen synthase kinase-3b (Cordes and van Beuningen, 2003; Hannigan et al., 2005) 
. Studies have identified ILK as a direct target of PPAR-b (Di-Poi et al., 2002).
For these reasons, we further performed quantitative PCR and found that the mRNA encoding ILK was significantly upregulated by the knockdown of PPAR-b, whereas the mRNA of integrin-b1 was not altered. This result implies that PPAR-b may inhibit the cellfibronectin adhesion of colon cancer by inhibiting the expression of ILK but has no effect on integrin-b1. ANGPTL4 has been shown to prevent the cell migration and invasiveness of tumors by inhibiting vascular activity and is a putative target of PPAR-b (Galaup et al., 2006; Holly et al., 2008) . However, using quantitative PCR, in this study we did not find the alteration of the mRNA encoding this gene, indicating that PPAR-b does not modulate the expression of ANGPTL4 and has no effect on the migration and invasion of colon cancer.
Interestingly, we noticed that the effect of PPAR-b knockdown on cell morphology, CEA production and cell-fibronectin adhesion decreased from poorly metastatic KM12C cells to highly metastatic KM12SM and KM12L4a cells. As shown above, KM12C cells showed greater morphological changes after PPAR-b knockdown than did KM12SM and KM12L4a cells using hematoxylin and eosin staining. The fold change of either CEA secretion or adhesion ability was obviously greater in KM12C than in KM12SM cells, with KM12L4a cells showing the least changes. These findings indicate that the effects of PPAR-b on the differentiation and adhesion of colon cancer cells are inversely associated with the metastatic potential of cells. Studies on genetics have shown that the karyotype of the KM12C cell line is near diploid, whereas KM12SM and KM12L4a cell lines are near tetraploid (Yeatman et al., 1996) . Compared with KM12C, both the number and rate of chromosomal gains and losses increase in KM12SM and KM12L4a cell lines. The KM12L4a cell line, which was established by four selection cycles, has more genetic alterations than does the KM12SM cell line, which was only selected once (Camps et al., 2004) . Although the chromosome portion (6p21.1-21.2) encoding PPAR-b is not altered in these cell lines, the activity of the PPAR-b gene may be affected by these genetic changes, which possibly underlies the different degrees of influence of PPAR-b on the three cell lines. On the other hand, the decreased effect of PPAR-b may be responsible for the increased metastatic potentials of KM12SM and KM12L4a cells. As a nuclear receptor involved in multiple physiological regulations (Cheng et al., 2004; Kim et al., 2004; Piqueras et al., 2007) , PPAR-b is an ideal drug target for the treatment of diseases. Studies have shown a wide range of PPAR-b agonists, including eicosanoids, fatty acids and some synthetic compounds (for example, GW501516); GW501516 is currently in a phase II clinical trial for dyslipidemia (Barish et al., 2006; Peraza et al., 2006; Takahashi et al., 2006) . Because of its protective role in the carcinogenesis and progression of colon cancer as suggested in this study, PPAR-b may be a potential drug target for colon cancer.
In conclusion, in this study we show that the specific knockdown of PPAR-b in KM12C, KM12SM and KM12L4a cells results in obviously more malignant morphologies, larger colonies and less CEA production, and enhances cell-fibronectin adhesion, without effects on cell invasion and migration. Consistent with these findings, PPAR-b knockdown simultaneously alters the expression of the related targets, including the downregulation of ADRP and L-FABP and the upregulation of ILK, whereas the expression of integrin b1 and ANGPTL4 is unchanged. These findings indicate that PPAR-b may facilitate differentiation and inhibit the cell-fibronectin adhesion of colon cancer, having a protective role in the carcinogenesis and progression of colon cancer. Further immunohistochemistry analysis reveals the close associations of PPAR-b expression with the differentiation and tumor-node-metastasis stage of rectal cancer, which strongly supports the findings in the cell lines in this study. Interestingly, the effects of PPAR-b on the differentiation and adhesion of colon cancer are negatively associated with metastatic potential.
Materials and methods
Cell lines
Three human colon cancer cell lines, KM12C, KM12SM and KM12L4a (from Professor IJ Fidler, Anderson Cancer Center, TX, USA), were used as target cells, maintained in Eagle's minimal essential medium (MEM) with Earle's salts, l-glutamine and nonessential amino acids (Sigma-Aldrich), supplemented with 1.5% NaHCO 3 , 1 mm Na-Pyruvate (Invitrogen, Carlsbad, CA, USA), 1 Â MEM Vitamin Solution (Invitrogen), 1% penicillin-streptomycin (Invitrogen) and 10% fetal bovine serum (Invitrogen). The KM12C cell line was derived from Dukes' B-stage colon cancer and implanted into the spleen or cecum of nude mice to produce liver metastasis. The liver metastases from cecum were cultured to establish KM12SM, and the liver metastases from spleen were selected from three additional cycles to establish KM12L4a cells. Therefore, KM12C cells were poorly metastatic, and KM12SM and KM12L4a cells had highly metastatic potentials (Morikawa et al., 1988) .
A modified human embryonic kidney cell line, 293 T (American Type Culture Collection, Manassas, VA, USA), was used for virus production and titration. Cells were maintained in Dulbecco's modified Eagle's medium (Gibco, Carlsbad, CA, USA), supplemented with 10% fetal bovine serum (Invitrogen), 0.7 mM L-glutamine (Sigma-Aldrich) and 5% penicillin-streptomycin (Invitrogen).
Lentivirus-mediated RNA interference
The lentivirus carrying short hairpin RNA, targeting PPAR-b or without RNA interference effect, was constructed by cotransfecting 293 T cells with lentiviral plasmids (see Supplementary Material), designated as Lenti-shPPAR-b and Lenticontrol, respectively. The short hairpin RNA sequences used were the following: sense, 5 0 -AGAAGGCCCGCAGCAT CCT-3 0 and antisense, 5 0 -AGGATGCTGCGGGCCTTCT-3 0 . The KM12C, KM12SM and KM12L4a cells were transduced with lentivirus using the spinoculation method (Doherty et al., 2000) . In brief, 3.0 Â 10 5 of cells were seeded in triplicate in sixwell plates with 2 ml complete MEM medium. After 24 h of incubation, the medium of each well was replaced with 2 ml viral suspension supplemented with 5 mg/ml polybrene (SigmaAldrich). The multiplicity of infection of the virus was around 2-3. The plates were then centrifuged for 1.5 h (20 1C, 1200 g), followed by a 5-h incubation in standard condition, and media were replaced with fresh MEM. After 48 h of additional incubation, cells were passaged into 25 cm 2 flasks and maintained under standard conditions. The enhanced green fluorescent protein expression profile of transduced cells was observed using Leica DM IL HC fluorescent microscope (Leica Microsystems Wetzlar GmbH, Wetzlar, Germany) and was determined at 48 h after transduction using FACSCalibur (Becton Dickinson, San Jose, CA, USA).
Real-time reverse-transcription-PCR
Total RNA was extracted from log-phase cells using the TurboCapture mRNA Kit (Qiagen, Hilden, Germany), followed by reverse transcription with a high-capacity complementary DNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA). The mRNAs encoding PPAR-b, ADRP, L-FABP, ANGPTL4, ILK and integrin-b1 were quantified using real-time reverse transcriptase-PCR analysis. PCR reaction was performed on the Applied Biosystems 7500 Fast Real-Time PCR System, using the comparative threshold cycle (Ct) method (DDCt) as described before (Yang et al., 2006) . The primers and TaqMan probes used to quantify mRNAs were listed in Table 4 . The PCR mastermix was prepared using TaqMan Fast Universal PCR Master Mix (Applied Biosystems) as follows: 1 Â Fast Master Mix, 1 ml complementary DNA, 200 nM TaqMan probe and 900 nM of each primer (Sigma-Aldrich), up to a total volume of 15 ml for each reaction. The amplification condition was as follows: denaturation at 95 1C for 20 s, amplification and quantification programs repeated 40 times (95 1C for 3 s, 60 1C for 30 s). Expression was normalized to b-actin, and 1 Â mix of b-actin primers and probes (Pre-developed TaqMan Assay Reagents, Applied Biosystems) was used for detection. Each sample was analysed in triplicate.
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Western blot assay
Total proteins were extracted using 1 Â radioimmunoprecipitation assay lysis buffer (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and the concentrations were assayed using Bicinchoninic acid Protein Assay (Pierce, Rockford, IL, USA). Each 20 mg aliquot of total protein was loaded in 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel, and then transferred onto a 0.2 mm polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA, USA). After complete protein transfer, the membrane was blocked in 5% (w/v) skimmed milk in phosphate-buffered saline and incubated overnight with a PPAR-b-specific antibody (polyclonal rabbit anti-mouse immunoglobulin G, 0.3 mg/ml, Aviva Systems Biology, San Diego, CA, USA). The blots were detected by the secondary antibody, horseradish peroxidase-linked polyclonal goat anti-rabbit immunoglobulin G (0.1 mg/ml, DakoCytomation, Denmark), and visualized using the Amersham ECL Plus Western Blot detection System (Amersham Biosciences/GE Healthcare, London, UK). PPAR-b expression was normalized to the level of glyceraldehyde-3-phosphate dehydrogenase detected by the rabbit monoclonal antibody (0.04 mg/ml, Cell Signaling, Danvers, MA, USA) and secondary antibody.
Morphology observation
The morphological alterations of cells were analysed using Ehrlich hematoxylin and eosin staining, scanning electronic microscopy and transmission electronic microscopy (see Supplementary Material).
Colony formation experiment
Log-phase cells were seeded in triplicate in six-well plates with 2 ml complete MEM (400 cells per well), and incubated at 37 1C in a humidified incubator. Plates were initially examined using a microscope to confirm that only single cells without clumps had been plated. At 5 days after plating, colonies were fixed with 4% formaldehyde and stained with 5% Giemsa in 95% ethanol. Colonies were visualized using an Olympus IX51 microscope and pictures were taken using an Olympus DP70 camera and DP controller software (Olympus, Tokyo, Japan). The colonies in a diameter of >0.3 mm were counted under light microscope at Â 3 magnification, and colony formation efficiencies was determined by the percentage of colonies per well.
Carcinoembryonic antigen (CEA) measurement Cells (2 Â 10 6 ) were seeded into a 25 cm 2 tissue-culture flask with complete MEM and incubated for 2 days. The medium was then changed with 3 ml fresh complete MEM and cells were incubated for 3 additional days . The medium was then harvested and centrifuged at 900 r.p.m. for 5 min, and the supernatant was stored at À20 1C till use. CEA was measured by a quantitative enzyme-linked immunosorbent assay kit (Fujirebio Diagnostics AB, Gothenburg, Sweden) according to the manufacturer's instructions. In brief, samples, calibrators or controls (available in the kit) were incubated with a biotinylated anti-CEA monoclonal antibody and horseradish peroxidase-labeled anti-CEA monoclonal antibody in streptavidin-coated microstrips. After washing, buffered substrate (hydrogen peroxide and tetra-methylbenzidine) was added to each well and the enzyme reaction was allowed to proceed. The color intensity of each well was determined on a microplate reader (Anthos ht II, Salzburg, Austria) at 405 nm. Calibration curves were constructed for each assay by plotting absorbance value versus the concentration for each calibrator. The CEA concentrations of samples were then read from the calibration curve and normalized to nanograms per 10 6 cells.
Cell adhesion assay
The extracelluar matrix adhesion assay was performed using CytoMatrix 96-well cell adhesion strips (Chemicon, Temecula CA, USA). Cells were suspended in complete MEM at 1 Â 10 6 cells/ml, and 100 ml of the suspension was added in triplicate into fibronectin-coated wells and incubated at 37 1C for 1 h in a humidified incubator. Nonadherent cells were removed by washing gently thrice with phosphate-buffered saline, and adherent cells were fixed and stained by 0.2% crystal violet in 10% ethanol. The adherent cells were visualized with an Olympus IX51 microscope and pictures were taken with an Olympus DP70 camera and software. Thereafter, 100 ml solubilization buffer was added to each well and strips were incubated with gentle shaking for 5 min at room temperature. The absorbance of each well was determined at 550 nm, which 
Abbreviations: ADRP, adipocyte differentiation-related protein; ANGPTL4, angiopoietin-like 4; F, forward primer; ILK, integrin-linked kinase; L-FABP, liver fatty acid binding protein; P, TaqMan probe; PPAR, peroxisome proliferator-activated receptor; R, reverse primer.
The role of PPAR-b in colon cancer L Yang et al was proportional to the amount of cells. In each assay, adhesion of cells to the wells coated with bovine serum albumin served as negative control.
Cell invasion and migration assays
Cell invasion and migration were assayed using a QCM 24-well cell invasion assay kit and a 96-well cell migration assay kit (Chemicon), respectively, based on the Boyden chamber principle (see Supplementary Material).
Patients and immunohistochemistry
This study included 77 patients with primary rectal cancer from the Southeast Swedish Health Care region. All patients underwent tumor resection alone, without pre-or postoperative adjuvant therapy. Informed consent was given by all participants. The characteristics of the patients and tumors are presented in Table 5 . Immunohistochemistry staining for PPAR-b expression was carried out on 5-mm sections from paraffin-embedded surgical specimens (see Supplementary Material). Sections known to show positive staining for PPAR-b were included in each run, receiving either the primary antibody or phosphate-buffered saline, as positive and negative controls. In all staining procedures, the positive controls showed clear staining, whereas there was no staining in negative controls. The slides were examined independently in a blinded manner by two investigators (Yang L and Zhang H) without information of clinicopathological data. The intensity in tumor cells was classified as negative, weak, moderate or strong. For statistical analysis, negative and weakly stained cases were considered as a weak-stained group, and the cases with moderate and strong staining were considered as a strong-stained group. To avoid artificial effect, the cells on the margins of sections and in areas with poor morphology were not counted. In cases in which the staining score had discrepant results, a consensus score was reached after reevaluation.
Statistical analysis
The relative expression of PPAR-b mRNA was analysed using the software REST-XL on the basis of the DDCt method (Yang et al., 2006) . Using SPSS 13.0 software (SPSS Inc., Chicago, IL, USA), the intensity of PPAR-b expression in relation to tumor clinicopathological factors was analysed using chi-square test, and the other data were analysed using one-way ANOVA and post hoc multiple comparison (LCD test). Po0.05 was taken as the significance level. Data shown represent at least three replicates of each experiment performed in triplicate. Abbreviation: TNM, tumor-node-metastasis.
